Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.75 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.75 |
| ▸ | HTT | P42858 | 3/20 | 0.75 |
| ▸ | LMNA | P02545 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 2/20 | 0.75 |
| ▸ | HPGD | P15428 | 2/20 | 0.75 |
| ▸ | PKM | P14618 | 1/20 | 0.75 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.65 |
| ▸ | CA3 | P07451 | 2/20 | 0.65 |
| ▸ | CA6 | P23280 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | CASP1 | P29466 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL204877 | 0.89 | CA12 (0.59) | ESR1ESR2HTTLMNAMAPT | |
| SCHEMBL62657 | 0.89 | CA12 (0.59) | ESR1ESR2HTTLMNAMAPT | |
| SCHEMBL9097535 | 0.89 | CA12 (0.59) | ESR1ESR2HTTLMNAMAPT | |
| Hydrochloric Acid SCHEMBL8640288 | 0.87 | CA12 (0.57) | ESR1ESR2HTTLMNAMAPT | |
| SCHEMBL699850 | 0.87 | LMNA (1.00) | ESR1ESR2HTTLMNAMAPT | |
| SCHEMBL18423 | 0.87 | LMNA (1.00) | ESR1ESR2HTTLMNAMAPT | |
| SCHEMBL728490 | 0.84 | HTT (0.65) | ESR1ESR2HTTLMNAMAPT | |
| Methane SCHEMBL6378712 | 0.84 | LMNA (0.94) | ESR1ESR2HTTLMNAMAPT | |
| SCHEMBL7929114 | 0.84 | LMNA (0.94) | ESR1ESR2HTTLMNAMAPT | |
| SCHEMBL29056089 | 0.84 | LMNA (0.94) | ESR1ESR2HTTLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119463112-B | Polymer compound and process for producing the same | 成都科成精化科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119463112-A | Polymer compound and process for producing the same | 成都科成精化科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-2546258-B1 | Novel phosphorus-containing compounds and their preparing process and use | CHANG CHUN PLASTICS CO LTD (TW) | 2015-12-16 | — | — | EP | claimed |
| EP-2546258-A1 | Novel phosphorus-containing compounds and their preparing process and use | Chang Chun Plastics Co., Ltd. (TW) | 2013-01-16 | — | — | EP | claimed |
| US-8222441-B2 | Phosphorus-containing compounds and their preparing process and use | CHANG CHUN PLASTICS CO., LTD. (TW) | 2012-07-17 | — | — | US | claimed |
| EP-2116549-A2 | Novel phosphorus-containing compounds and their preparing process and use | Chang Chun Plastics Co., Ltd. (TW) | 2009-11-11 | — | — | EP | claimed |
| US-20090258997-A1 | Novel phosphorus-containing compounds and their preparing process and use | CHANG CHUN PLASTICS CO., LTD. | 2009-10-15 | — | — | US | claimed |
| CN-119463112-B | Polymer compound and process for producing the same | 成都科成精化科技有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119463112-A | Polymer compound and process for producing the same | 成都科成精化科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-11866584-B2 | High-refractive-index composition, high-refractive-index film, and method for manufacturing high-refractive-index film | LG CHEM, LTD. (KR) | 2024-01-09 | — | — | US | disclosed |
| US-20230355644-A1 | ACTIVE INGREDIENTS AND DRUGS FOR THE THERAPY OF VIRAL DISEASES, ESPECIALLY CORONA INFECTIONS, ESPECIALLY COVID-19 | CREATIVE THERAPEUTICS GMBH (DE) | 2023-11-09 | — | — | US | disclosed |
| US-20230355644-A1 | ACTIVE INGREDIENTS AND DRUGS FOR THE THERAPY OF VIRAL DISEASES, ESPECIALLY CORONA INFECTIONS, ESPECIALLY COVID-19 | CREATIVE THERAPEUTICS GMBH (DE) | 2023-11-09 | — | — | US | disclosed |
| CN-116554234-A | Ferrocene-pyrazole hybrid compound as well as preparation method and application thereof | 桂林医学院附属医院 | 2023-08-08 | — | — | CN | disclosed |
| EP-0469492-A2 | Polymer modified adducts of epoxy resins and active hydrogen containing compounds containing mesogenic moieties | THE DOW CHEMICAL COMPANY (US) | 1992-02-05 | — | — | EP | disclosed |
| US-4820798-A | Cyanate functional maleimide thermosetting composition | THE DOW CHEMICAL COMPANY (US) | 1989-04-11 | — | — | US | disclosed |
| US-4820797-A | ACETYLENIC COPOLYMERS | THE DOW CHEMICAL COMPANY (US) | 1989-04-11 | — | — | US | disclosed |
| US-4769440-A | FLEXIBILITY | THE DOW CHEMICAL COMPANY (US) | 1988-09-06 | — | — | US | disclosed |
| US-4731426-A | Polymerization product from cyanate functional maleimide | THE DOW CHEMICAL COMPANY (US) | 1988-03-15 | — | — | US | disclosed |
| US-4683276-A | CASTING, LAMINATION, COATING | THE DOW CHEMICAL COMPANY (US) | 1987-07-28 | — | — | US | disclosed |
| US-4680378-A | Cyanate functional maleimide and polyamine copolymer | THE DOW CHEMICAL COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355644-A1 | ACTIVE INGREDIENTS AND DRUGS FOR THE THERAPY OF VIRAL DISEASES, ESPECIALLY CORONA INFECTIONS, ESPECIALLY COVID-19 | ACE, ACE2, SARS1 | ESR1 2909/4885ESR2 2529/4885HTT 1074/4885 |
| US-20090258997-A1 | Novel phosphorus-containing compounds and their preparing process and use | POLR2A, POLR2B, PRXL2A | ESR1 154/4885ESR2 65/4885HTT 4799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.